T/SCGS 313005-2023 Active Group standards

T/SCGS 313005-2023 The construction and experimental method of magnetic resonance imaging-based colorectal cancer neoadjuvant therapy efficacy evaluation and tissue-based proteomics model

T/SCGS 313005-2023 The construction and experimental method of magnetic resonance imaging-based colorectal cancer neoadjuvant therapy efficacy evaluation and tissue-based proteomics model

Publish Date: 2023-08-04 Implement Date: 2023-08-05 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 26.00
Out of stock

Basic Information

Standard Code: T/SCGS 313005-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medical devices
ICS Name: Comprehensive Technical Drawing
Publish Date: 2023-08-04
Implement Date: 2023-08-05
Pages: 16 pages

Scope

This document specifies the performance evaluation methods and assessment indicators for magnetic resonance imaging (MRI) omics models used to evaluate the efficacy of neoadjuvant therapy for rectal cancer.
This document is applicable to the research, development, clinical practice, and translation of auxiliary decision-making models and systems based on imaging omics methods in issues related to the prediction and evaluation of the efficacy of neoadjuvant therapy for rectal cancer.

Development Information

Word Count: 25 Thousand words Pages: 16 pages

Referenced Standards

Related Standards

Contact Us